The CIBM PET HUG-UNIGE is specialized in molecular imaging using Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT).

These advanced imaging modalities allow for the in vivo visualization, characterization, and quantification of biological processes at cellular and sub-cellular levels.

The section offers a wide range of preclinical applications across diverse fields - including oncology, neurology and neurodegenerative diseases, metabolism, and cardiology - to researchers from the University of Geneva as well as external collaborators.

Perfect bridge between bench and bedside, preclinical imaging is the state-of-the-art method to validate in vitro results and efficiently translate preclinical results into clinical settings.

In line with the 3Rs principles (Reduce, Replace, Refine) preclinical imaging minimizes animal use through longitudinal imaging, high translational relevance, and refined, non-invasive protocols.